Rationalities and non-rationalities in clinical encounters: Methadone maintenance treatment and hormone replacement therapy

Science as Culture

Volumn 18, Issue 2, 2009, Pages 165-181

  Roberts, Celia ^a   Valentine, Kylie ^b   Fraser, Suzanne ^c  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Clinical encounter; Hormone replacement therapy; Methadone; Pharmaceuticals; Rationality

Indexed keywords

EID: 84861652224     PISSN: 09505431     EISSN: 14701189     Source Type: Journal    
DOI: 10.1080/09505430902885524     Document Type: Article

References (44)

1. Butler, J., 1990. Gender Trouble:Feminism and the Subversion of Identity, New York and London:Routledge.
2. Coney, S., 1991. The Menopause Industry:A Guide to Medicine's ‘Discovery’ of the Midlife Women, Melbourne:Spinifex Press.
3. Elwyn, G., Edwards, A., Gwyn, R., and Grol, R., 1999. Towards a feasible model for shared decision making:focus group study with general practitioners. British Medical Journal, 319 18 September:753–756.
4. Ettinger, B., 1998. Overview of estrogen replacement therapy:a historical perspective. Proceedings of the Society for Experimental Biology and Medicine, 217 (1):2–5.
5. Evidence-Based Medicine Working Group. 1992. Evidence-based medicine:a new approach to teaching the practice of medicine. Journal of the American Medical Association, 268 (17):2420–2425.
6. Farrell, E., 2003. Medical choices available for management of menopause. Best Practice and Research in Clinical Endocrinology and Metabolism, 17 (1):1–16.
7. Ferzacca, S., 2000. “Actually, I don't feel that bad”:managing diabates and the clinical encounter. Medical Anthropology Quarterly, 14 (1):28–50.
8. Fraser, N., and Gordon, L., 1997. “ A genealogy of ‘dependency’:tracing a keyword of the US welfare state ”. In Justice Interruptus:Critical Reflections on the ‘Postsocialist’ Condition, Edited by:Fraser, N., New York and London:Routledge.
9. Fraser, S., 2003. Cosmetic Surgery, Gender and Culture, Basingstoke:Palgrave.
10. Fraser, S., 2006. The chronotope of the queue:methadone maintenance treatment and the production of time, space and subjects. International Journal of Drug Policy, 17:192–202.
11. Gatens, M., 1996. Imaginary Bodies, London and New York:Routledge.
12. Guillemin, M., 2000a. Blood, bone, women and HRT:co-construction in the menopause clinic. Australian Feminist Studies, 15 (32):191–203.
13. Guillemin, M., 2000b. Working practices of the menopause clinic. Science, Technology and Human Values, 25 (4):448–470.
14. TM:Feminism and Technoscience, New York and London:Routledge.
15. Health Promotion England. 2000. The Menopause:The Facts about the Menopause, HRT and Osteoporosis, London:National Health Service.
16. Hedgecoe, A., 2005. ‘At the point at which you can do something about it, then it becomes more relevant’:informed consent in the pharmacogenetic clinic. Social Science & Medicine, 61 (6):1201–1210.
17. Henwood, F., Wyatt, S., Hart, A., and Smith, J., 2003. ‘Ignorance is bliss sometimes’:constraints on the emergence of the ‘informed patient’ in the changing landscapes of health information. Sociology of Health and Illness, 25 (6):589–607.
18. Hird, Myra J., 2004. Sex, Gender and Science, Houndsmill, Basingstoke, Hamphire and New York:Palgrave.
19. Hoffman, M., Lindh-Åstran, L., Ahlner, J., Hammer, M., and Kjellgren, Karin I., 2005. Hormone replacement therapy in the menopause:structure and content of risk talk. Maturitas, 50 (1):8–15.
20. Holmes-Rovner, M., and Rovner, D. R., 2000. Measuring improved patient choice. Journal of Evaluation in Clinical Practice, 6 (3):263–272.
21. Hunter, Myra S., O'Dea, I., and Britten, N., 1997. Decision-making and hormone replacement therapy:a qualitative analysis. Social Science and Medicine, 45 (10):1541–1548.
22. Jamrozik, A., and Sweeney, T., 1996. Children and Society:The Family, the State and Social Parenthood, Melbourne:Macmillan.
23. Low, L. F., and Anstey, K. J., 2006. Hormone replacement therapy and cognitive performance in postmenopausal women—a review by cognitive domain. Neuroscience and Biobehavioural Reviews, 30 (1):66–84.
24. Marsh, B., 2002. Why the HRT generation has a fun-filled life. The Daily Mail,:30 Wednesday 8 May
25. Mitteness, Linda S., 1983. Historical changes in public information about the menopause. Urban Anthropology, 12 (2):61–179.
26. Mol, A., 2002. The Body Multiple:Ontology in Medical Practice, Durham and London, NC:Duke University Press.
27. Mol, A., 2008. The Logic of Care:Health and the Problem of Patient Choice, London and New York:Routledge.
28. Murray, J., 2001. Is it Me, or is it Hot in Here? A Modern Woman's Guide to the Menopause, London:Vermillion.
29. Murtagh, M. J., and Hepworth, J., 2003. Menopause as a long-term risk to health:implications of general practitioner accounts of prevention for women's choice and decision-making. Sociology of Health and Illness, 25 (2):185–207.
30. NSW Health. 2001. Treatment Agreement:Conditions of Methadone/Buprenorphine Treatment, Sydney:Centre for Drug & Alcohol, NSW Department of Health.
31. NSW Health. 2006. NSW Opioid Treatment Program:Clinical Guidelines for Methadone and Buprenorphine Treatment of Opioid Dependence, Sydney:Mental Health and Drug & Alcohol Office, NSW Department of Health.
32. Oudshoorn, N., 1994. Beyond the Natural Body:An Archeology of Sex Hormones, London and New York:Routledge.
33. Prevelic, G. M., and Jacobs, H. S., 1997. Menopause and postmenopause. Clinical Endocrinology and Metobolism, 11 (2):313–340.
34. Rayner, C., 2002. Why it is worth taking the risk. The Guardian, Thursday 11 July. Available at:www.guardianunlimited.co.uk (accessed 2 February 2007)
35. Reuben, D., 1971. All You Ever Wanted to Know About Sex, But Were Afraid to Ask, New York:HarperCollins.
36. Roberts, C., 2000. Biological behavior? Hormones, psychology and sex. The Science and Politics of the Search for Sex Differences:A Special Issue of the NWSA Journal, 12 (3):1–20.
37. Roberts, C., 2002. ‘Successful aging’ with hormone replacement therapy:it may be sexist, but what if it works?. Science as Culture, 11 (1):39–59.
38. Roberts, C., 2006. ‘What can I do to help myself?’ Somatic individuality and contemporary hormonal bodies. Science Studies, 19 (2):54–76.
39. Salmon, P., and Hall, G. M., 2003. Patient empowerment and control:a psychological discourse in the service of medicine. Social Science & Medicine, 57 (10):1969–1980.
40. Sedgwick, E. K., 1992. “ Epidemics of the will ”. In Incorporations, Edited by:Crary, J., and Kwinter, S., New York:Zone.
41. Sherwin, B., 1998. Estrogen and cognitive functioning in women. Proceedings of the Society for Experimental Biology and Medicine, 217 (1):17–22.
42. Shumaker, S. A., 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment. Journal of the American Medical Association, 289:2651–2662.
43. Valverde, M., 1998. Diseases of the Will:Alcohol and the Dilemmas of Freedom, Cambridge, Melbourne and New York:Cambridge University Press.
44. Wilson, R. A., 1966. Feminine Forever, London:Mayflower-Dell.